Creative Biolabs Service
Creative Biolabs provides custom aptamer services for projects that need new target-binding sequences. We design selection around the target format, binding context, specificity question, and downstream research use. The goal is to move from a defined selection problem to prioritized candidates with an agreed evidence package for the next step.
An aptamer discovery project is defined by more than the target name. Target format, binding context, specificity goals, partitioning, and downstream use all affect how selection should be designed.
Creative Biolabs uses these inputs to shape a custom discovery plan. We first decide what the library must recognize and what it must ignore. We then choose a target presentation and selection route that can answer that question.
Target type changes how the target can be presented, how bound sequences are separated, and which controls are most informative. Choose the route that matches the real recognition problem.
For defined protein targets that can be presented in a controlled selection format. If purification or a simplified construct may change the relevant target state, Native-Context Protein Aptamer Selection may be a better fit.
For low-molecular-weight compounds where target chemistry, presentation, partitioning, and selectivity against related molecules shape the selection plan.
For metal-ion targets where buffer composition, competing ions, coordination conditions, and selectivity controls need dedicated planning.
For projects involving several defined targets when the selection design must coordinate recognition, specificity, and prioritization across known targets.
For heterogeneous or multi-component preparations where the useful recognition problem cannot be reduced to a set of individually defined targets.
For intact-cell or phenotype-level recognition when native cell-surface context and matched counter cells are central to the project.
For projects in which tissue, organ, or organism context is part of the selection environment and cannot be reproduced by a simpler target format.
Target identity, available format, concentration range, stability, and any constraints on immobilization or handling.
Homologs, analogs, related cells, matrix components, or other known off-targets that should influence selection pressure.
Buffer, sample matrix, target presentation, partitioning constraints, and other conditions that may affect binding.
The research readout helps define how candidates should be prioritized and what validation should follow discovery.
Selection pressure should become more informative as the pool evolves. Positive selection enriches target-binding sequences, while counter or subtractive steps can remove sequences that prefer known off-targets, supports, matrices, or background components. The timing and strength of these controls depend on the target and the required discrimination.
For projects centered on known off-target depletion, Counter-SELEX or Subtractive SELEX can be considered as dedicated selection strategies.
An enriched pool is an intermediate result. Candidate prioritization should combine sequence information with evidence that the selected molecules still answer the original binding question.
Compare how the pool changes across selection rounds and controls rather than relying on one endpoint signal.
Use sequencing and sequence-family information to find candidates that warrant direct testing.
Compare candidate binding in the target format that is relevant to the project.
Test the most important counter targets, analogs, or background conditions before selecting leads for the next stage.
Published SELEX analyses show that choices made during selection, amplification, and sequencing can change which sequences dominate a pool.1 Candidate evaluation is therefore kept separate from enrichment alone.
The next step depends on how much evidence is already available for the lead candidates and what the aptamer must do in the final research context.
Measure binding and specificity in greater depth before choosing a development lead.
Refine a selected sequence around length, stability, chemistry, or another defined performance question.
Adapt a known binder to a required research format when the sequence needs further design work.
Move a suitable aptamer into an assay concept after the relevant binding and sample questions are defined.
Discovery creates and prioritizes candidate binders. Characterization starts with known candidates and measures their binding or other defined properties in greater depth.
Start with how the target exists in the intended binding context. A purified protein, a low-molecular-weight compound, and a whole cell create different presentation and partitioning problems.
No. Target format, specificity goals, available materials, and downstream use are more useful starting points. The selection route can be discussed during project scoping.
Yes, when they represent a real specificity risk. Their timing and selection pressure should be chosen to remove unwanted binders without discarding useful diversity too early.
No. Enrichment shows that some sequences are becoming more represented, but individual candidates still need direct binding and specificity evaluation.
Target identity and format, available material, known off-targets, sample context, intended use, and the desired candidate evaluation are useful starting points.
Share your target, available material, and the main specificity question. Creative Biolabs can help define a focused discovery route and the evidence needed for candidate handoff.
